Medical marvel: This female-founded startup uses 3D bioprinting to mimic tumour environment for cancer treatment, gets £4.2M funding
Amount Raised
£4.2 Million
Round Type
Funding Round
Investors
Description
Carcinotech has raised £4.2 million in its latest funding round to advance its Carcino3D technology and expand its operations in the UK, Europe, and the US.
Who else raised in Biotechnology Research around the same time
Companies in the same sectors as Carcinotech Ltd that raised within 45 days of this round, from Fundz verified event records.
- Baseimmune raised $11M (Series A) on February 26, 2024.
- eFeed raised $10M (Seed) on February 21, 2024.
- VRG Therapeutics raised $15M (Series B) on February 20, 2024.
- Colipi raised $1.9M (Seed) on February 19, 2024.
- FreezeM raised $14M (Series A) on February 15, 2024.
- SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.
Who to call at Carcinotech Ltd, and when
A new round usually means Carcinotech Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Carcinotech Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Carcinotech Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Carcinotech Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Carcinotech Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Carcinotech Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.